Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.
<h4>Background</h4>Beneficial effects of short-term erythropoietin (EPO) therapy have been demonstrated in several animal models of acute neurologic injury, including experimental autoimmune encephalomyelitis (EAE)--the animal model of multiple sclerosis. We have found that EPO treatment...
Guardado en:
Autores principales: | RuiRong Yuan, Yasuhiro Maeda, Weiping Li, Wei Lu, Stuart Cook, Peter Dowling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e05c479295244a3a92913d5c11b788fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021) -
Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
por: Al-ani MR, et al.
Publicado: (2020) -
Modulation of autoimmune pathogenesis by T cell-triggered inflammatory cell death
por: Katsuhiro Sasaki, et al.
Publicado: (2019) -
Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MS
por: Jifang Gao, et al.
Publicado: (2017) -
IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).
por: Agnieszka Rynda, et al.
Publicado: (2010)